Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus [Phase 2]
Phase 2 clinical trial investigating combination chemotherapy for metastatic or recurrent gastric (stomach) and esophageal cancers; the curr…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer [Phase 1]
Phase 1 clinical trial update for LMB-9 immunotoxin in patients with advanced pancreatic, esophageal, gastric, or colorectal cancer.
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: SU006668 in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 update on the investigational drug SU006668 being studied in patients with advanced solid tumors, including breast cancer and colore…
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles [Phase 2]
Phase 2 trial evaluating enoxaparin thromboprophylaxis in cancer patients with elevated tissue factor-bearing microparticles has completed w…
-
CLINICAL_TRIALS research · 2013-12-11Clinical Trial Update: Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer [Phase 3]
This document summarizes a Phase 3 clinical study evaluating Endostar injections in combination with the SOX chemotherapy protocol for advan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer [Phase 1, Phase 2]
A combination of AMG 102 with ECX (epirubicin, cisplatin, capecitabine) was evaluated in Phase 1/2 for unresectable locally advanced or meta…
-
CLINICAL_TRIALS research · 2013-12-05Clinical Trial Update: Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma
A clinical trial update examining how c-MET expression and amplification relate to prognosis and pathology in gastric cancer.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection [Phase 2]
A Phase II clinical trial evaluating catumaxomab in gastric cancer patients who received neoadjuvant chemotherapy and curative resection has…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery [Phase 2]
Phase 2 clinical trial update of nitrocamptothecin in patients with locally advanced or metastatic gastric or esophageal cancer; sponsor is …
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Functional Jejunal Interposition Improve Nutritional Status After Total Gastrectomy [Phase 3]
A Phase 3 clinical trial is evaluating whether functional jejunal interposition after total gastrectomy improves nutritional status in patie…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer [Phase 2]
Phase 2 trial evaluating cetuximab in combination with S-1 and cisplatin in gastric cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: Clinical Study for Energy Based Devices in Open Gastrectomy for Gastric Cancer [Phase 3]
A Phase 3 clinical study evaluating energy-based devices in open gastrectomy for gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib [Phase 3]
A Phase III global trial update (LOGiC) evaluated chemotherapy plus lapatinib in HER2-positive gastric cancer, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-10-24Clinical Trial Update: Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors [NA]
A completed clinical trial evaluating how imatinib affects bone metabolism in patients with chronic myelogenous leukemia or gastrointestinal…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.
This is a completed clinical trial update evaluating intraoperative cell saver autotransfusion during major surgical oncology operations. Th…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: The Study of Irinotecan Plus Epirubicin as the Second-line Chemoregime for Advanced Gastric Cancer [Phase 2]
The document reports an ongoing Phase 2 clinical trial evaluating irinotecan plus epirubicin as second-line chemotherapy for advanced gastri…
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC [Phase 2]
A Phase 2 trial evaluating continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin for gastric cancer has completed.
-
CLINICAL_TRIALS research · 2013-10-16Clinical Trial Update: A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC [Phase 2]
Phase II clinical trial update exploring predictive factors for TX and XELOX regimens as first-line treatment in gastric cancer.
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: The Effect of Nutritional Counseling for Cancer Patients [Phase 4]
This document provides an update on a Phase 4 clinical trial evaluating nutritional counseling for cancer patients. The study includes patie…
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis [Phase 4]
Phase 4 clinical trial update evaluating preoperative chemotherapy with bevacizumab for potentially resectable gastric cancer with liver met…
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: The Efficacy of Topical Bupivacaine and Triamcinolone Acetonide Injection in the Relief of Pain After Endoscopic Submucosal Dissection for Gastric Neoplasia: A Randomized Double-blind, Placebo-controlled Trial [NA]
A randomized, double-blind, placebo-controlled trial evaluated the efficacy of topical bupivacaine and triamcinolone acetonide injections fo…
-
CLINICAL_TRIALS research · 2013-10-11Clinical Trial Update: Lymph Node Staging System With a Novel Concept for Gastric Cancer: a Hybrid Type of Topographic and Numeric Ones
A completed clinical trial evaluating a novel hybrid lymph node staging approach that combines topographic and numeric criteria for gastric …
-
CLINICAL_TRIALS trial_result · 2013-10-09Clinical Trial Update: Fast Track Surgery With Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer: a Randomized Controlled Trial [NA]
A completed randomized controlled trial assessing fast-track surgery with laparoscopic-assisted gastrectomy for advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating MK-2206 (AKT inhibitor) with lapatinib and trastuzumab in unresectable locally advanced or metastatic HER2-positive…
-
CLINICAL_TRIALS research · 2013-09-19Clinical Trial Update: Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer [Phase 2]
This clinical trial investigates a combination of Nimotuzumab, Capecitabine, and radiotherapy for inoperable or recurrent gastric cancer in …